KUMAMOTO University

R

研究業績RESEARCH ACHIEVEMENTS

  1. Onishi C, Nishikori M, Yakushijin K, Kurahashi S, Nakazawa H, Takamatsu Y, Hashimoto Y, Tatetsu H, Nawa Y, Yoshida M, Kobayashi T, Oyake T, Yano S, Oride A, Suzuki R.

    Lymphoma during pregnancy in Japan: a multicenter retrospective cohort study.

    Int J Hematol 115(3):382-390,2022. doi: 10.1007/s12185-021-03281-w.

    https://pubmed.ncbi.nlm.nih.gov/34981434/

     

  2. Nosaka K, Crawford B, Yi J, Kuan W, Matsumoto T, Takahashi T.

    Systematic review of survival outcomes for relapsed or refractory adult T-cell leukemia-lymphoma.

    Eur J Haematol 108(3):212-222,2022.  doi: 10.1111/ejh.13728.

    https://pubmed.ncbi.nlm.nih.gov/34862665/

     

  3. Zhao T, Wang Z, Fang J, Chengc W, Zhang Y, Huang J, Xu L, Zeng L, Jin Z, and Matsuoka M.

    HTLV-1 activates YAP by NF-κB/p65 to promote oncogenesis.

    Proc Natl Acad Sci USA  119(9):e2115316119,2022. doi: 10.1073/pnas.2115316119.

    https://pubmed.ncbi.nlm.nih.gov/35210364/

  4. Shichijo T, Tatetsu H, Nosaka K, Higuchi Y, Kikukawa Y, Inoue Y, Toyoda K, Yasunaga JI, Matsuoka M.

    Predictive impact of soluble interleukin-2 receptor and number of extranodal sites for identification of patients at very high risk of CNS relapse in diffuse large B-cell lymphoma.

    eJHaem 1–9,2022.

    https://onlinelibrary.wiley.com/doi/10.1002/jha2.393

     

  5. Fuchida S, Kawamura K, Sunami K, Tsukada N, Fujii S, Ohkawara H, Usuki K, Wake A, Endo S, Ishiyama K, Ueda Y, Nakamura Y, Miyamoto T, Fukuda T, Ichinohe T, Atsuta Y, Takamatsu H.

    Retrospective Analysis of Autologous Stem Cell Transplantation for AL Amyloidosis: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation.

    Transplant Cell Ther 28(2):76-82,2022.  doi: 10.1016/j.jtct.2021.10.021.

    https://pubmed.ncbi.nlm.nih.gov/34774818/

     

  6. Fuchida SI, Kawamura K, Sunami K, Tsukada N, Fujii S, Ohkawara H, Usuki K, Wake A, Endo S, Ishiyama K, Ueda Y, Nakamura Y, Miyamoto T, Fukuda T, Ichinohe T, Atsuta Y, Takamatsu H.

    Amyloidosis: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation.

    Transplant Cell Ther 28(2):76-82,2022. doi: 10.1016/j.jtct.2021.10.021

    https://pubmed.ncbi.nlm.nih.gov/34774818/

     

  7. Kogure Y, Kameda T, Koya J, Yoshimitsu M, Nosaka K, Yasunaga JI, Imaizumi Y, Watanabe M, Saito Y, Ito Y, McClure MB, Tabata M, Shingaki S, Yoshifuji K, Chiba K, Okada A, Kakiuchi N, Nannya Y, Kamiunten A, Tahira Y, Akizuki K, Sekine M, Shide K, Hidaka T, Kubuki Y, Kitanaka A, Hidaka M, Nakano N, Utsunomiya A, Sica RA, Acuna-Villaorduna A, Janakiram M, Shah UA, Ramos JC, Shibata T, Takeuchi K, Takaori-Kondo A, Miyazaki Y, Matsuoka M, Ishitsuka K, Shiraishi Y, Miyano S, Ogawa S, Ye BH, Shimoda K, Kataoka K.

    Whole-genome landscape of adult T-cell leukemia/lymphoma.

    Blood 139(7):967-982,2022. doi: 10.1182/blood.2021013568.

    https://pubmed.ncbi.nlm.nih.gov/34695199/

  8. Nosaka K, Kusumoto S, Nakano N, Choi I, Yoshimitsu M, Imaizumi Y, Hidaka M, Sasaki H, Makiyama J, Ohtsuka E, Jo T, Ogata M, Ito A, Yonekura K, Tatetsu H, Kato T, Kawakita T, Suehiro Y, Ishitsuka K, Iida S, Matsutani T, Utsunomiya A, Ueda R, Ishida T.

    Clinical significance of the immunoglobulin G heavy-chain repertoire in peripheral blood mononuclear cells of adult T-cell leukemia-lymphoma patients receiving mogamulizumab.

    Br J Haematol 196(3):629-638,2022. doi: 10.1111/bjh.17895. Epub 2021 Oct 10.

    https://pubmed.ncbi.nlm.nih.gov/34632569/

  9. Kunitomo K, Hirano T, Tsuji T.

    Numerous Schistocytes in thrombotic thrombocytopenic purpura.

    2022 Feb 1;98(e1):e33.doi: 10.1136/postgradmedj-2020-139308.

    https://pubmed.ncbi.nlm.nih.gov/33095337/

  10. Katsuya H, Cook LBM, Rowan AG, Melamed A, Turpin J, Ito J, Islam S, Miyazato P, Jek Yang Tan B, Matsuo M, Miyakawa T, Nakata H, Matsushita S, Taylor GP, Bangham CRM, Kimura S, Satou Y.

    Clonality of HIV-1- and HTLV-1-Infected Cells in Naturally Coinfected Individuals.

    J Infect Dis 18;225(2):317-326,2022.doi: 10.1093/infdis/jiab202.

  11. Higuchi Y, Yasunaga JI, Matsuoka M.

    HTLV-1’s foxy strategy for survival and Transmission.

    Front Virol doi: 10.3389/fviro.2021.792659,2022.

    https://www.frontiersin.org/articles/10.3389/fviro.2021.792659/full

  12. Masayuki Amano, Ravikiran S Yedidi, Pedro Miguel Salcedo-Gómez, Hironori Hayashi, Kazuya Hasegawa, Cuthbert D Martyr, Arun K Ghosh, Hiroaki Mitsuya.

    Fluorine-Modifications Contribute to Potent Antiviral Activity against Highly Drug-Resistant HIV-1 and Favorable Blood-Brain Barrier (BBB) Penetration Property of Novel Central Nervous System (CNS)-targeting HIV-1 Protease Inhibitors In Vitro.

    Antimicrob Agents Chemother. 2022 Jan 3; AAC0171521. doi: 10.1128/AAC.01715-21.

    https://journals.asm.org/doi/10.1128/AAC.01715-21

    https://pubmed.ncbi.nlm.nih.gov/34978889/

     

     

  13. Kawano Y, Sasano T, Arima Y, Kushima S, Tsujita K, Matsuoka M, Hata H.

    A novel PDK1 inhibitor, JX06, inhibits glycolysis and induces apoptosis in multiple myeloma cells.

    Biochem Biophys Res Commun 587: 153-159,2022. doi: 10.1016/j.bbrc.2021.11.102.

    https://pubmed.ncbi.nlm.nih.gov/34875534/

     

  14. Inoue Y, Nakano N, Fuji S, Eto T, Kawakita T, Suehiro Y, Miyamoto T, Sawayama Y, Uchida N, Kondo T, Kanda J, Atsuta Y, Fukuda T, Yoshimitsu M, Kato K, ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation.

    Impact of conditioning intensity and regimen on transplant outcomes in patients with adult T-cell leukemia-lymphoma.

    Bone Marrow Transplant 56(12):2964-2974,2021.  doi: 10.1038/s41409-021-01445-0.

    https://pubmed.ncbi.nlm.nih.gov/34462567/

     

  15. Hiyoshi M, Takahashi N, Eltalkhawy YM, Noyori O, Lotfi S, Panaampon J, Okada S, Tanaka Y, Ueno T, Fujisawa JI, Sato Y, Suzuki T, Hasegawa H, Tokunaga M, Satou Y, Yasunaga JI, Matsuoka M, Utsunomiya A, Suzu S.

    M-Sec induced by HTLV-1 mediates an efficient viral transmission.

    PLoS Pathog 17(11):e1010126,2021.  doi: 10.1371/journal.ppat.1010126.

    https://pubmed.ncbi.nlm.nih.gov/34843591/

  16. Tanaka T, Nakamae H, Ito A, Fuji S, Hirose A, Eto T, Henzan H, Takase K, Yamasaki S, Makiyama J, Moriuchi Y, Choi I, Nakano N, Hiramoto N, Kato K, Sato T, Sawayama Y, Kim SW, Inoue Y, Inamoto Y, Fukuda T.

    A Phase I/II Multicenter Trial of HLA-Haploidentical PBSCT with PTCy for Aggressive Adult T Cell Leukemia/Lymphoma.

    Transplant Cell Ther 27(11):928 e1-e7,2021.doi: 10.1016/j.jtct.2021.07.010

    https://pubmed.ncbi.nlm.nih.gov/34274491/

  17. Kenji Maeda, Masayuki Amano, Yukari Uemura, Kiyoto Tsuchiya, Tomoko Matsushima, Kenta Noda, Yosuke Shimizu, Asuka Fujiwara, Yuki Takamatsu, Yasuko Ichikawa, Hidehiro Nishimura, Mari Kinoshita, Shota Matsumoto, Hiroyuki Gatanaga, Kazuhisa Yoshimura, Shin-Ichi Oka, Ayako Mikami, Wataru Sugiura, Toshiyuki Sato, Tomokazu Yoshida, Shinya Shimada, Hiroaki Mitsuya.

    Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals.

    Sci Rep. 2021 Nov 24;11(1):22848. doi: 10.1038/s41598-021-01930-y.

    https://pubmed.ncbi.nlm.nih.gov/34819514/

     

  18. Fujimoto Y, Ueno S, Oda K, Gunda N, Shimomura Y, Nishimura Y, Yamaguchi A, Kuwano A, Ito Y, Baba Y, Nishigaki A, Michiwaki N, Uchino S, Kurogi K, Kawano Y, Matsuoka M, Saito H, Okuno Y, Jono H.

    Relationship between serum bortezomib concentration and emergence of diarrhea in patients with multiple myeloma and/or AL amyloidosis.

    Cancers 13(22),5674,2021. doi: 10.3390/cancers13225674.

    https://pubmed.ncbi.nlm.nih.gov/34830830/

     

     

  19. Ito A, Nakano N, Tanaka T, Fuji S, Makiyama J, Inoue Y, Choi I, Nakamae H, Nagafuji K, Takase K, Machida S, Takahashi T, Sawayama Y, Kamimura T, Kato K, Kawakita T, Ogata M, Sakai R, Shiratori S, Uchimaru K, Inamoto Y, Utsunomiya A, Fukuda T.

    Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study.

    Blood Adv 5(20):4156-66,2021. doi: 10.1182/bloodadvances.2021004932.

    https://pubmed.ncbi.nlm.nih.gov/34500464/

  20. Abdallah MG, Niibori-Nambu A, Morii M, Yokomizo T, Yokomizo T, Ideue T, Kubota S, Teoh VSI, Mok MMH, Wang CQ, Omar AA, Tokunaga K, Iwanaga E, Matsuoka M, Asou N, Nakagata N, Araki K, AboElenin M, Madboly SH, Sashida G, Osato M.

    RUNX1-ETO (RUNX1-RUNX1T1) induces myeloid leukemia in mice in an age-dependent manner.

    Leukemia 35(10):2983-2988,2021. doi: 10.1038/s41375-021-01268-4

    https://pubmed.ncbi.nlm.nih.gov/34148054/

     

  21. Ito S, Iwanaga M, Nosaka K, Imaizumi Y, Ishitsuka K, Amano M, Utsunomiya A, Tokura Y, Watanabe T, Uchimaru K, Tsukasaki K, Collaborative Investigators.

    Epidemiology of adult T-cell leukemia-lymphoma in Japan: An updated analysis, 2012-2013.

    Cancer Sci 112(10):4346-4354,2021. doi: 10.1111/cas.15097.

    https://pubmed.ncbi.nlm.nih.gov/34355480/

     

  22. Inoue Y, Okinaka K, Fuji S, Inamoto Y, Uchida N, Toya T, Ikegame K, Eto T, Ozawa Y, Iwato K, Kanda Y, Atsuta Y, Ogata M, Fukuda T, Transplant Complications Working Group of The Japan Society for Hematopoietic Cell Transplantation.

    Severe acute graft-versus-host disease increases the incidence of blood stream infection and mortality after allogeneic hematopoietic cell transplantation: Japanese transplant registry study.

    Bone Marrow Transplant 56(9):2125-36,2021.  doi: 10.1038/s41409-021-01291-0.

    https://pubmed.ncbi.nlm.nih.gov/33875815/

     

  23. Izutsu K, Ando K, Nishikori M, Shibayama H, Teshima T, Kuroda J, Kato K, Imaizumi Y, Nosaka K, Sakai R, Hojo S, Nakanishi T, Rai S.

    Phase II study of tazemetostat for relapsed or refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan.

    Cancer Sci 112(9):3627-3635,2021. doi: 10.1111/cas.15040.

    https://pubmed.ncbi.nlm.nih.gov/34159682/

     

  24. Ono A, Kitano Y, Imai K, Matsumoto T, Endo S, Tokunaga K, Hayashi H, Yamashita YI, Matsuoka M, Baba H.

    A case of primary nonleukemic myeloid sarcoma of the spleen, successfully treated by surgery and hematopoietic stem cell transplantation.

    Surg Case Rep 7(1):180,2021. doi: 10.1186/s40792-021-01257-w.

    https://pubmed.ncbi.nlm.nih.gov/34379239/

     

CONTACT US

C

  • 患者様へ

    外来診療の方は外来予約センターより
    ご予約をお願いいたします。
    外来予約センター

  • 学生・研修医・医療関係者の方へ

    TEL
    096-373-5156
    FAX
    096-373-5158
    Mail
    nikyo*kumamoto-u.ac.jp
    (*はアットマーク)
Copyright 2019 KUMAMOTO University HRI All Rights Reserved.